Search

Gossamer Bio Inc

Cerrado

SectorSanidad

10.69 -10.17

Resumen

Variación precio

24h

Actual

Mínimo

10.68

Máximo

12.26

Métricas clave

By Trading Economics

Ingresos

64M

17M

Ventas

-7.7M

9.2M

BPA

-0.2

Margen de beneficios

182.94

Empleados

161

EBITDA

-28M

-71M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

-90.03% downside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

65M

Apertura anterior

20.86

Cierre anterior

10.69

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

115 / 339 Clasificación en Healthcare

Gossamer Bio Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

18 sept 2026, 22:11 UTC

Gossamer Bio Inc has rallied sharply in after-market trading, rebounding from earlier losses and advancing significantly since Friday's close.

17 sept 2026, 20:07 UTC

News

Gossamer Bio Inc. shares are sharply higher as the company appointed Greg Ciongoli to its Board of Directors, effective September 16, 2026.

16 sept 2026, 20:10 UTC

Gossamer Bio Inc's stock price is sharply higher in Wednesday's trading session, recovering from an initial dip to peak above Tuesday's close.

15 sept 2026, 21:05 UTC

Gossamer Bio Inc. shares traded lower in after-market hours, remaining below the 20-day moving average and near the lower end of their one-month range.

14 sept 2026, 20:07 UTC

Gossamer Bio Inc. shares are higher today amid broader market dynamics, despite ongoing concerns about rising crude oil prices and their inflationary effects.

11 sept 2026, 23:01 UTC

Gossamer Bio Inc. shares are higher in after-hours trading, reflecting a notable increase since Friday's close amid positive market sentiment following a narrower U.S. budget deficit.

10 sept 2026, 23:31 UTC

Event

Gossamer Bio Inc. shares rose in after-market trading following a 1-for-80 reverse stock split, advancing from earlier levels despite broader market dynamics.

9 sept 2026, 23:53 UTC

Gossamer Bio Inc. shares are lower in after-market hours following a significant decline since Wednesday's close, despite an earlier attempt to recover.

4 sept 2026, 19:26 UTC

Gossamer Bio shares are lower today amid increased selling pressure on risk assets, influenced by strong jobs data and rising interest rate expectations.

3 sept 2026, 23:26 UTC

Gossamer Bio Inc shares are lower in after-market hours, with no specific news identified for the decline. Major indices rose amid reduced interest rate hike expectations.

2 sept 2026, 23:06 UTC

Gossamer Bio Inc. shares are higher in after-market trading, remaining above their 20-day moving average and within the one-month trading range.

1 sept 2026, 23:06 UTC

Gossamer Bio Inc. shares declined in after-market trading, influenced by rising oil prices and inflation concerns amid a broader performance below the 20-day moving average.

31 ago 2026, 20:07 UTC

Gossamer Bio Inc is higher today amid broader market reactions to potential Federal Reserve interest rate hikes following remarks from Warsh at the Jackson Hole symposium.

28 ago 2026, 23:06 UTC

Gossamer Bio Inc. shares are higher in after-market trading, reflecting positive momentum since Friday's close amid broader market volatility.

27 ago 2026, 23:01 UTC

News

Gossamer Bio announced a private placement that could yield up to $250 million, with an initial $25 million expected upfront. Shares are roughly flat in after-market hours.

26 ago 2026, 23:01 UTC

Gossamer Bio Inc is higher in after-market trading, reflecting broader market gains amid positive economic data on personal consumption and durable goods orders.

25 ago 2026, 23:01 UTC

Gossamer Bio shares were lower in after-market hours, with no specific news identified. The broader market retreated after an initial advance amid falling crude oil prices.

24 ago 2026, 23:01 UTC

Gossamer Bio Inc. shares are lower in after-market trading amid notable volatility and ongoing geopolitical tensions involving the U.S. and Iran.

22 ago 2026, 00:01 UTC

Gossamer Bio Inc. shares advanced in after-market trading, recovering from earlier lows amid broader market gains despite no specific company news identified.

21 ago 2026, 23:01 UTC

Gossamer Bio Inc shares are higher in after-market hours, following broader market gains despite earlier lower trading. No specific news was identified for the move.

20 ago 2026, 23:01 UTC

Gossamer Bio shares are lower in after-market trading, reflecting broader market pressures following Walmart's disappointing sales growth and guidance.

19 ago 2026, 23:01 UTC

Gossamer Bio Inc shares are higher in after-market hours, following a notable peak earlier in the session. The stock remains below its 20-day moving average.

18 ago 2026, 23:01 UTC

Gossamer Bio Inc shares rose in after-market trading following Tuesday's close, though no specific news was identified to explain the movement.

17 ago 2026, 23:31 UTC

Gossamer Bio Inc shares are sharply higher in after-market trading, rising significantly despite being below its 20-day moving average and recent declines.

15 ago 2026, 00:01 UTC

Gossamer Bio Inc shares are higher in after-market hours, though no specific news explains the movement. The price remains below its 20-day moving average.

14 ago 2026, 22:51 UTC

Gossamer Bio Inc. shares are higher in after-market hours, despite disappointing U.S. retail sales data influencing broader market sentiment.

13 ago 2026, 23:01 UTC

News

Gossamer Bio reported second-quarter net income of $16.9 million and plans to submit a New Drug Application for seralutinib in September 2026. Shares are higher in after-market trading.

12 ago 2026, 23:01 UTC

Gossamer Bio Inc. shares advanced in after-market trading, continuing a strong performance since July 13, despite earlier fluctuations during the session.

11 ago 2026, 23:11 UTC

No specific news was identified for Gossamer Bio Inc. in after-market trading, with shares effectively unchanged since Tuesday's close.

10 ago 2026, 23:01 UTC

Gossamer Bio Inc. shares are higher in after-hours trading, reflecting strong performance and positioning above the 20-day moving average. No specific news was identified.

Comparación entre iguales

Cambio de precio

Gossamer Bio Inc previsión

Precio Objetivo

By TipRanks

-90.03% descenso

Estimación a 12 Meses

Media 1.07 USD  -90.03%

Máximo 2 USD

Mínimo 0.28 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Gossamer Bio Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

2

Comprar

2

Mantener

1

Vender

Sentimiento

By Acuity

115 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Gossamer Bio Inc

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.